Six-minute walking test outweighs other predictors of mortality in idiopathic pulmonary fibrosis. A real-life study from the Swedish IPF registry-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Six-minute walking test outweighs other predictors of mortality in idiopathic pulmonary fibrosis. A real-life study from the Swedish IPF registry

Published:2020-11 Issue: Volume:2 Page:100017
ISSN:2590-1435
Container-title:Respiratory Medicine: X
language:en
Short-container-title:Respiratory Medicine: X

Author:

Pesonen Ida,Gao Jing,Kalafatis Dimitrios,Carlson Lisa,Sköld Magnus,Ferrara Giovanni

Funder

Swedish Heart-Lung Foundation

Karolinska Institutet

Karolinska University Hospital

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference35 articles.

1. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management;Raghu;Am. J. Respir. Crit. Care Med.,2011

2. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline;Raghu;Am. J. Respir. Crit. Care Med.,2015

3. Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group;Skold;J. Intern. Med.,2017

4. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study;Fernandez Perez;Chest,2010

5. Clinical course and prediction of survival in idiopathic pulmonary fibrosis;Ley;Am. J. Respir. Crit. Care Med.,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Real-World Multicenter Retrospective Observational Study on Polish Experience with Nintedanib Therapy in Patients with Idiopathic Pulmonary Fibrosis: The PolExNIB Study;Journal of Clinical Medicine;2023-07-12

2. Physical activity, exercise capacity and mortality risk in people with interstitial lung disease: A systematic review and meta-analysis;Journal of Science and Medicine in Sport;2022-11

3. Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension;Pulmonary Circulation;2022-10

4. Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis;Thorax;2022-03-24

5. Longitudinal and Comparative Measures of Serum Chitotriosidase and YKL-40 in Patients With Idiopathic Pulmonary Fibrosis;Frontiers in Immunology;2022-02-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3